[Federal Register Volume 77, Number 17 (Thursday, January 26, 2012)]
[Notices]
[Page 4026]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-1645]



[[Page 4026]]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License of U.S. Government-Owned 
Invention

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7(a)(1)(i) 
and 37 CFR 404.7(b)(1)(i), announcement is made of the intent to grant 
an exclusive, revocable license to the invention claimed in 
International Patent Application No. PCT/US2009/060852 entitled 
``Method and Device for Detection of Bioavailable Drug Concentration In 
A Fluid Sample,'' filed on October 15, 2009 (which claims the benefit 
of U.S. Provisional Patent Application Serial No. 61/105,604 filed 
October 15, 2008). The intended licensee is The University of Tennessee 
with its principal place of business at UT Conference Center, Suite 
211, 600 Henley Street, Knoxville, TN 37996-4122.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele, 
Office of Research & Technology Applications, (301) 619-6664. For 
patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808; 
both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this 
license can file written objections along with supporting evidence, if 
any, within 15 days from the date of this publication. Written 
objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2012-1645 Filed 1-25-12; 8:45 am]
BILLING CODE 3710-08-P